Trial · NCT02966834
Results by group814
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 814
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline at Week 16 in the Mean Worst Daily Itch Score | Placebo | -1.73 | 95% Confidence Interval -2.44 to -1.01 | Scores on a scale | |
| Mean Change From Baseline at Week 16 in the Mean Worst Daily Itch Score | GSK2330672 20 mg QD | -2.19 | 95% Confidence Interval -3.26 to -1.12 | Scores on a scale | |
| Mean Change From Baseline at Week 16 in the Mean Worst Daily Itch Score | GSK2330672 90 mg QD | -2.60 | 95% Confidence Interval -3.55 to -1.65 | Scores on a scale | |
| Mean Change From Baseline at Week 16 in the Mean Worst Daily Itch Score | GSK2330672 180 mg QD | -2.60 | 95% Confidence Interval -3.51 to -1.70 | Scores on a scale | |
| Mean Change From Baseline at Week 16 in the Mean Worst Daily Itch Score | GSK2330672 40 mg BID | -2.86 | 95% Confidence Interval -3.76 to -1.95 | Scores on a scale | |
| Mean Change From Baseline at Week 16 in the Mean Worst Daily Itch Score | GSK2330672 90 mg BID | -2.25 | 95% Confidence Interval -3.19 to -1.32 | Scores on a scale | |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | Placebo | Symptoms | 0.2 | 95% Confidence Interval -1.0 to 1.4 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | GSK2330672 20 mg QD | Symptoms | 0.4 | 95% Confidence Interval -1.3 to 2.2 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | GSK2330672 90 mg QD | Symptoms | 0.7 | 95% Confidence Interval -0.8 to 2.3 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | GSK2330672 180 mg QD | Symptoms | -0.9 | 95% Confidence Interval -2.4 to 0.6 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | GSK2330672 40 mg BID | Symptoms | 0.3 | 95% Confidence Interval -1.2 to 1.8 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | GSK2330672 90 mg BID | Symptoms | 0.2 | 95% Confidence Interval -1.4 to 1.8 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | Placebo | Itch | -2.3 | 95% Confidence Interval -3.3 to -1.4 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | GSK2330672 20 mg QD | Itch | -1.9 | 95% Confidence Interval -3.3 to -0.4 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | GSK2330672 90 mg QD | Itch | -2.6 | 95% Confidence Interval -3.9 to -1.3 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | GSK2330672 180 mg QD | Itch | -2.7 | 95% Confidence Interval -3.9 to -1.4 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | GSK2330672 40 mg BID | Itch | -3.4 | 95% Confidence Interval -4.6 to -2.1 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | GSK2330672 90 mg BID | Itch | -2.7 | 95% Confidence Interval -4.0 to -1.4 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | Placebo | Fatigue | -1.8 | 95% Confidence Interval -4.0 to 0.4 | Scores on a scale |
| Mean Change From Baseline at Week 16 in Primary Biliary Cholangitis-40 (PBC-40) Scale | GSK2330672 20 mg QD | Fatigue | -2.4 | 95% Confidence Interval -5.6 to 0.7 | Scores on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02966834/results